Norges Bank’s GenMark Diagnostics, Inc GNMK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-569,000
Closed -$13.6M 2298
2021
Q1
$13.6M Buy
+569,000
New +$10.6M ﹤0.01% 1693

Norges Bank's GNMK Position: Q2 2021 in Review

Norges Bank sold out of GenMark Diagnostics, Inc (GNMK) in Q2 2021, closing a stake of 569,000 shares — an estimated $13.6M sold.

Norges Bank first reported a position in GNMK in Q1 2021 and held it in 1 quarter. The position peaked at $13.6M in Q1 2021. 0 funds tracked by Wall St. Rank hold GNMK as of Q2 2021.

  • Norges Bank reported no remaining GenMark Diagnostics, Inc position as of Q2 2021 after selling out during the quarter.
  • Norges Bank sold 569,000 GenMark Diagnostics, Inc shares in Q2 2021, an estimated $13.6M.
  • Norges Bank first reported a position in GenMark Diagnostics, Inc in Q1 2021 and held it in 1 quarter.
  • Norges Bank's GenMark Diagnostics, Inc position peaked at $13.6M in Q1 2021.
  • 0 funds tracked by Wall St. Rank held GenMark Diagnostics, Inc as of Q2 2021.

Based on Norges Bank's 13F filing for Q2 2021, filed 10 Aug 2021.